{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T22:51:19Z","timestamp":1770159079093,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"vor","delay-in-days":137,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejoncologynursing.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Oncology Nursing"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ejon.2021.101997","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T13:38:37Z","timestamp":1624628317000},"page":"101997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Symptom prevalence and health-related quality of life in patients undergoing autologous stem cell transplantation \u2013 A longitudinal observational study"],"prefix":"10.1016","volume":"53","author":[{"given":"Simone Lena","family":"Stamm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Spichiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Pabst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Bachnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0275-4602","authenticated-orcid":false,"given":"Marie-Madlen","family":"Jeitziner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejon.2021.101997_bib1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/sj.bmt.1705664","article-title":"Symptom burden in patients undergoing autologous stem-cell transplantation","volume":"39","author":"Anderson","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ejon.2021.101997_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1200\/JCO.2005.03.189","article-title":"Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation","volume":"23","author":"Andrykowski","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejon.2021.101997_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.12968\/hmed.2019.80.1.33","article-title":"Haematopoietic stem cell transplants: principles and indications","volume":"80","author":"Balassa","year":"2019","journal-title":"Br. J. Hosp. Med."},{"key":"10.1016\/j.ejon.2021.101997_bib4","first-page":"2411","article-title":"Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice","volume":"24","author":"Beijers","year":"2016","journal-title":"Support. Care Canc."},{"key":"10.1016\/j.ejon.2021.101997_bib5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2648.2009.05179.x","article-title":"Building dynamic models and theories to advance the science of symptom management research","volume":"66","author":"Brant","year":"2010","journal-title":"J. Adv. Nurs."},{"key":"10.1016\/j.ejon.2021.101997_bib6","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/cncr.23299","article-title":"Symptom burden after autologous stem cell transplantation for multiple myeloma","volume":"112","author":"Campagnaro","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ejon.2021.101997_bib7","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1182\/blood-2011-02-297325","article-title":"International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation","volume":"117","author":"Cavo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ejon.2021.101997_bib8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejon.2021.101997_bib9","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.bbmt.2018.03.027","article-title":"Health-related quality of life after autologous stem cell transplantation for multiple myeloma","volume":"24","author":"Chakraborty","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.ejon.2021.101997_bib10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jpainsymman.2011.08.011","article-title":"Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation","volume":"44","author":"Cohen","year":"2012","journal-title":"J. Pain Symptom Manag."},{"issue":"12","key":"10.1016\/j.ejon.2021.101997_bib11","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.3390\/cancers11122037","article-title":"Pain management in patients with multiple myeloma: an update","volume":"11","author":"Coluzzi","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ejon.2021.101997_bib12","first-page":"2449","article-title":"Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines","volume":"28","author":"Correa","year":"2020","journal-title":"Support. Care Canc."},{"key":"10.1016\/j.ejon.2021.101997_bib13","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.12968\/bjon.2016.25.S18","article-title":"Multiple myeloma: managing a complex blood cancer","volume":"25","author":"Dowling","year":"2016","journal-title":"Br. J. Nurs."},{"key":"10.1016\/j.ejon.2021.101997_bib14","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1188\/04.ONF.937-944","article-title":"Fatigue and depression in patients with lymphoma undergoing autologous peripheral blood stem cell transplantation","volume":"31","author":"El-Banna","year":"2004","journal-title":"Oncol. Nurs. Forum"},{"key":"10.1016\/j.ejon.2021.101997_bib15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1188\/08.ONF.449-454","article-title":"Understanding the concept of uncertainty in patients with indolent lymphoma","volume":"35","author":"Elphee","year":"2008","journal-title":"Oncol. Nurs. Forum"},{"key":"10.1016\/j.ejon.2021.101997_bib16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/bmt.2011.107","article-title":"Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European organization for research and treatment of cancer (EORTC) quality of life core questionnaire QLQ-C30","volume":"47","author":"Grulke","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ejon.2021.101997_bib17","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1200\/JCO.1999.17.2.706","article-title":"Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study","volume":"17","author":"Hjermstad","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejon.2021.101997_bib18","first-page":"38","article-title":"Drug-induced peripheral neuropathy: a narrative review","volume":"15","author":"Jones","year":"2020","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.ejon.2021.101997_bib19","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0885-3924(00)00144-5","article-title":"High level of fatigue in lymphoma patients treated with high dose therapy","volume":"19","author":"Knobel","year":"2000","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.ejon.2021.101997_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.soncn.2017.05.004","article-title":"Hematopoietic stem cell transplantation for multiple myeloma","volume":"33","author":"Koniarczyk","year":"2017","journal-title":"Semin. Oncol. Nurs."},{"key":"10.1016\/j.ejon.2021.101997_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/sj.bmt.1704709","article-title":"Routine screening for psychosocial distress following hematopoietic stem cell transplantation","volume":"35","author":"Lee","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ejon.2021.101997_bib22","author":"Lymphoma Coalition - Worldwide Network of Lymphoma Patient Groups"},{"key":"10.1016\/j.ejon.2021.101997_bib23","doi-asserted-by":"crossref","DOI":"10.1590\/1518-8345.2474.3065","article-title":"Hematopoietic stem cell transplantation and quality of life during the first year of treatment","volume":"26","author":"Marques","year":"2018","journal-title":"Rev Lat Am Enfermagem"},{"key":"10.1016\/j.ejon.2021.101997_bib24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.bmt.1700672","article-title":"Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale","volume":"19","author":"McQuellon","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ejon.2021.101997_bib25","first-page":"833","article-title":"Symptom experience of multiple myeloma (syMMex) patients treated with autologous stem cell transplantation following high-dose melphalan: a descriptive longitudinal study","volume":"26","author":"Naegele","year":"2018","journal-title":"Support. Care Canc."},{"key":"10.1016\/j.ejon.2021.101997_bib26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/bmt.2008.3","article-title":"Pain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies","volume":"41","author":"Niscola","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ejon.2021.101997_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0973-1075.125558","article-title":"Symptoms after hospital discharge following hematopoietic stem cell transplantation","volume":"20","author":"Oguz","year":"2014","journal-title":"Indian J. Palliat. Care"},{"key":"10.1016\/j.ejon.2021.101997_bib28","doi-asserted-by":"crossref","first-page":"w14589","DOI":"10.4414\/smw.2018.14589","article-title":"Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss blood stem cell transplantation working group for blood and marrow transplantation registry 1997-2016","volume":"148","author":"Passweg","year":"2018","journal-title":"Swiss Med. Wkly."},{"issue":"8","key":"10.1016\/j.ejon.2021.101997_bib29","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/s41409-020-0826-4","article-title":"The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus","volume":"55","author":"Passweg","year":"2020","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ejon.2021.101997_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2141.2009.07992.x","article-title":"Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention","volume":"148","author":"Pidala","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejon.2021.101997_bib31","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/0959-8049(94)90182-1","article-title":"The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress","volume":"30A","author":"Portenoy","year":"1994","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.ejon.2021.101997_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1188\/05.ONF.57-67","article-title":"Quality of life, quality of care, and patient satisfaction: perceptions of patients undergoing outpatient autologous stem cell transplantation","volume":"32","author":"Schulmeister","year":"2005","journal-title":"Oncol. Nurs. Forum"},{"key":"10.1016\/j.ejon.2021.101997_bib33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbmt.2008.09.023","article-title":"Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation","volume":"15","author":"Sherman","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.ejon.2021.101997_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejon.2010.06.005","article-title":"Symptom prevalence and changes of symptoms over ten days in hospitalized patients with advanced cancer: a descriptive study","volume":"15","author":"Spichiger","year":"2011","journal-title":"Eur. J. Oncol. Nurs."},{"key":"10.1016\/j.ejon.2021.101997_bib35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00012272-200510000-00005","article-title":"Symptom management in HIV\/AIDS: advancing the conceptualization","volume":"28","author":"Spirig","year":"2005","journal-title":"ANS Adv Nurs Sci"},{"key":"10.1016\/j.ejon.2021.101997_bib36","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0277-9536(99)00045-3","article-title":"Integrating response shift into health-related quality of life research: a theoretical model","volume":"48","author":"Sprangers","year":"1999","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.ejon.2021.101997_bib37","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/bmt.2015.6","article-title":"Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015","volume":"50","author":"Sureda","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ejon.2021.101997_bib38","series-title":"H\u00e4matopoetische Stammzelltransplantation in der Schweiz 2019","year":"2020"},{"key":"10.1016\/j.ejon.2021.101997_bib39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-1-79","article-title":"The functional assessment of chronic illness therapy (FACIT) measurement System: properties, applications, and interpretation","volume":"1","author":"Webster","year":"2003","journal-title":"Health Qual. Life Outcome"},{"key":"10.1016\/j.ejon.2021.101997_bib40","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/pon.1240","article-title":"Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument","volume":"17","author":"Wettergren","year":"2008","journal-title":"Psycho Oncol."},{"key":"10.1016\/j.ejon.2021.101997_bib41","first-page":"863","article-title":"Analysis of nurse navigators' activities for hospital discharge coordination: a mixed method study for the case of cancer patients","volume":"25","author":"Yatim","year":"2017","journal-title":"Support. Care Canc."},{"key":"10.1016\/j.ejon.2021.101997_bib42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11899-017-0382-1","article-title":"A review of autologous stem cell transplantation in lymphoma","volume":"12","author":"Zahid","year":"2017","journal-title":"Curr Hematol Malig Rep"}],"container-title":["European Journal of Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388921001034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388921001034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T20:22:06Z","timestamp":1761423726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1462388921001034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":42,"alternative-id":["S1462388921001034"],"URL":"https:\/\/doi.org\/10.1016\/j.ejon.2021.101997","relation":{},"ISSN":["1462-3889"],"issn-type":[{"value":"1462-3889","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Symptom prevalence and health-related quality of life in patients undergoing autologous stem cell transplantation \u2013 A longitudinal observational study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejon.2021.101997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101997"}}